1. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. Issue 7 (19th July 2021) Authors: Guidon, Amanda C; Burton, Leeann B; Chwalisz, Bart K; Hillis, James; Schaller, Teilo H; Amato, Anthony A; Betof Warner, Allison; Brastianos, Priscilla K; Cho, Tracey A; Clardy, Stacey L; Cohen, Justine V; Dietrich, Jorg; Dougan, Michael; Doughty, Christopher T; Dubey, Divyanshu; Gelfand, Jeffrey ... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Issue 12 (December 2020) Authors: Muppidi, Srikanth; Guptill, Jeffrey T; Jacob, Saiju; Li, Yingkai; Farrugia, Maria E; Guidon, Amanda C; Tavee, Jinny O; Kaminski, Henry; Howard, James F; Cutter, Gary; Wiendl, Heinz; Maas, Matthew B; Illa, Isabel; Mantegazza, Renato; Murai, Hiroyuki; Utsugisawa, Kimiaki; Nowak, Richard J; Guidon, ... Journal: Lancet neurology Issue: Volume 19:Issue 12(2020) Page Start: 970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Issue 2 (February 2022) Authors: Punga, Anna Rostedt; Maddison, Paul; Heckmann, Jeannine M; Guptill, Jeffrey T; Evoli, Amelia Journal: Lancet neurology Issue: Volume 21:Issue 2(2022) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗